Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Tables)

v3.22.2.2
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2022
Accounting Policies [Abstract]  
Schedule of Other Receivables

 

As of

 

 

September 30, 2022

 

 

December 31, 2021

 

Payroll tax withholding and exercise proceeds receivable

$

9

 

 

$

8,477

 

Construction receivable

 

8,034

 

 

 

5,574

 

Income tax receivable

 

1,891

 

 

 

4,935

 

Insurance receivable

 

2,977

 

 

 

2,594

 

Other

 

1,530

 

 

 

1,216

 

Total other receivables

$

14,441

 

 

$

22,796

 

Schedule of Inventory

Inventory consisted of the following for the periods presented:

 

As of

 

 

September 30, 2022

 

 

December 31, 2021

 

Chemical washing solutions

$

9,063

 

 

$

6,406

 

Other

 

-

 

 

 

52

 

Total inventory, gross

 

9,063

 

 

 

6,458

 

Reserve for obsolescence

 

(175

)

 

 

(124

)

Total inventory, net

$

8,888

 

 

$

6,334

 

Schedule of Composition of Revenue

The following table summarizes the composition of the Company’s net revenues for the periods presented:

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Recognized over time

$

150,873

 

 

$

127,825

 

 

$

440,809

 

 

$

358,456

 

Recognized at a point in time

 

66,590

 

 

 

66,026

 

 

 

220,420

 

 

 

206,087

 

Other revenue

 

113

 

 

 

459

 

 

 

925

 

 

 

2,355

 

Net revenues

$

217,576

 

 

$

194,310

 

 

$

662,154

 

 

$

566,898

 

 

Schedule of Reconciliations of Numerators and Denominators of Basic and Diluted Net (Loss) Income Per Share Reconciliations of the numerators and denominators of the basic and diluted net income per share calculations for the periods presented are as follows:

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

$

23,997

 

 

$

27,366

 

 

$

95,144

 

 

$

(58,350

)

 

 

 

 

 

 

 

 

 

 

 

 

Denominator:

 

 

 

 

 

 

 

 

 

 

 

Weighted-average common shares outstanding - basic

 

304,290,590

 

 

 

296,360,660

 

 

 

302,641,749

 

 

 

274,387,532

 

Effect of potentially dilutive securities:

 

 

 

 

 

 

 

 

 

 

 

Stock options

 

22,377,790

 

 

 

30,251,223

 

 

 

24,433,580

 

 

 

-

 

Restricted stock units

 

154,987

 

 

 

652,019

 

 

 

678,005

 

 

 

-

 

Employee stock purchase plan

 

57,785

 

 

 

56,267

 

 

 

20,010

 

 

 

-

 

Weighted-average common shares outstanding - diluted

 

326,881,152

 

 

 

327,320,169

 

 

 

327,773,344

 

 

 

274,387,532

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) per share - basic

$

0.08

 

 

$

0.09

 

 

$

0.31

 

 

$

(0.21

)

Net income (loss) per share - diluted

$

0.07

 

 

$

0.08

 

 

$

0.29

 

 

$

(0.21

)

Schedule of Antidilutive Shares Excluded from Computation of Diluted (Loss) Net Income Per Share

The following potentially dilutive shares were excluded from the computation of diluted net income per share for the periods presented because including them would have been antidilutive:

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Stock options

 

2,384,530

 

 

 

2,086,437

 

 

 

2,188,289

 

 

 

33,773,922

 

Restricted stock units

 

15,165

 

 

 

-

 

 

 

60,612

 

 

 

1,592,524

 

Employee stock purchase plan

 

7,186

 

 

 

-

 

 

 

34,466

 

 

 

244,751